Outcomes According to Breast Cancer Subtype in Patients Treated With Accelerated Partial Breast Irradiation

Five-year local control rates after breast-conserving surgery, APBI, and appropriate systemic therapy are excellent for luminal, HER2, and basal phenotypes of early-stage breast cancer; however, further study of receptor subtype effect on risk stratification in early-stage breast cancer is needed.